Tag: pharmaceuticals

  • R&D Collaboration to Discover Drugs for River Blindness

    Anacor Pharmaceuticals in Palo Alto California, the University of California San Francisco’s Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center established a research and development collaboration to discover new therapies to treat river blindness (onchocerciasis). River blindness is a parasitic disease and the second leading cause of…

  • GSK, Nottinghan Univ. to Collaborate on Green Chemistry

    The BBC is reporting that the global drug manufacturer GlaxoSmithKline (GSK) will build a new lab at the University of Nottingham in the U.K. for research and education in cleaner and safer chemistry processes. The proposal is expected to be presented first as a proof-of-concept in 2011, for construction at the University’s Jubilee Campus, one…

  • Trial Shows Drug Effect on ALS Blood Biomarker

    Neuraltus Pharmaceuticals in Palo Alto, California said today an early stage clinical trial of its drug NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) showed improvement in a blood biomarker associated with the disease with patients taking the drug. ALS is a disease of the nerve cells in the brain…

  • Study: Youth Prescriptions Nearly Double Since 1994

    Adolescents and young adults are most likely to abuse prescription medications, which after marijuana is their illicit drug of choice. Yet prescription rates for controlled medications have nearly doubled for those age groups in the past 14 years, according to a study published online in the journal Pediatrics. Overall, a controlled medication was prescribed for…

  • University Licenses Nanoparticle Drug Delivery Technology

    The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD), both in Vancouver, Canada, said today that Covidien, a Dublin, Ireland provider of health care products, has licensed a drug-delivery platform technology invented by UBC researcher, Pieter Cullis. CDRD provided the development facilities and commercialization services that led to this…

  • Study Shows Drug Combo Effective as HIV Prevention

    A new study called iPrEx shows that individuals at high risk for HIV infection who took a once-a-day commercially-available tablet containing two widely used HIV medications experienced fewer HIV infections than those who received a placebo pill. The researchers say that the clinical trial, reported in the New England Journal of Medicine, is the first…

  • Macular Degeneration Drug Achieves Goal in Clinical Trial

    Regeneron Pharmaceuticals Inc. in Tarrytown, New York and the German pharmaceutical company Bayer HealthCare said today that all regimens of their drug VEGF Trap-Eye (aflibercept ophthalmic solution) met their primary objectives in two separate Phase 3 clinical studies of patients with the neovascular form of age-related macular degeneration, often called wet AMD. VEGF Trap-Eye is…

  • FDA Approves Drug for Cancer-Related Bone Deterioration

    Amgen Inc., a biotechnology company in Thousand Oaks, California, said the U.S. Food and Drug Administration (FDA) has approved its drug XGEVA (denosumab), for the prevention of skeletal-related events in patients with bone cancers from solid tumors. The company says FDA approved XGEVA following a 6 month priority review by the FDA, a process reserved…

  • Late Stage Trial Shows Parkinson’s Drug Efficacy

    Biotechnology company Impax Laboratories Inc. in Hayward, California  says that a Phase 3 clinical trial of its drug IPX066 shows it is effective in patients with early Parkinson’s disease (PD), with side effects similar to related PD drugs in use. A Phase 3 trial studies a drug or treatment given to large groups of people…

  • Univ. Researchers Develop Dry Powder HPV Vaccine

    A new targeted, inhalable dry-powder human papillomavirus (HPV) vaccine, according to its developers,  can help overcome resistance from needle avoidance and offer better logistics than the current commercial HPV vaccine used worldwide. HPV is the number one cause of cervical cancer, which is the second most common cancer in women around the globe. According to…